CJA
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS

This Article
Right arrow Résumé de cet Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Submit a scholarly reply
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Missant, C.
Right arrow Articles by Van de Velde, M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Missant, C.
Right arrow Articles by Van de Velde, M.
Canadian Journal of Anesthesia 51:696-701 (2004)
© Canadian Anesthesiologists' Society, 2004

Obstetrical and Pediatric Anesthesia

Intrathecal clonidine prolongs labour analgesia but worsens fetal outcome: a pilot study

[L’administration intrathécale de clonidine prolonge l’analgésie du travail obstétrical, mais compromet l’évolution foetale: une étude pilote]

Carlo Missant, MD, An Teunkens, MD, Eugene Vandermeersch, MD PhD and Marc Van de Velde, MD PhD

From the Department of Anesthesiology, University Hospitals Gasthuisberg, Katholieke Universiteit Leuven, Leuven, Belgium.

Address correspondence to: Dr. Marc Van de Velde, Director Obstetric Anesthesia and Extra Muros Anesthesia, Department of Anesthesiology, University Hospitals Gasthuisberg, Herestraat 49, B - 3000 Leuven, Belgium. Phone: 32 16 34 42 70; Fax: 32 16 34 42 45; E-mail: marc.vandevelde{at}uz.kuleuven.ac.be

Purpose: Intrathecal clonidine prolongs total duration of spinal bupivacaine analgesia. However, there are contradictory reports about its effect on maternal blood pressure and only limited data are available on fetal and neonatal outcome. In this study, we evaluated the efficacy of spinal clonidine combined with ropivacaine and sufentanil and its effects on maternal and fetal outcome.

Methods: Fifty patients requesting combined spinal epidural analgesia for labour pain relief were randomly assigned to receive intrathecal ropivacaine 3 mg, sufentanil 1.5 µg with or without clonidine 30 µg. Onset time and duration of analgesia, visual analogue scores for pain, blood pressure, ephedrine requirements, heart rate, incidence of nausea, pruritus and motor blockade, umbilical artery pH, fetal heart rate abnormalities and Apgar scores were noted and analyzed.

Results: Patients receiving spinal clonidine had significantly longer lasting analgesia compared to patients treated without clonidine (122 ± 56 min vs 90 ± 36 min, P < 0.05). Clonidine-treated patients experienced a more pronounced decrease in mean arterial pressure as compared to patients treated without clonidine (25 ± 10% vs 15 ± 12%, P < 0.05). The groups also differed in ephedrine requirement (4.91 mg vs 0.75 mg, P < 0.05), number of new onset fetal heart rate abnormalities (28% vs 0%, P < 0.05) and umbilical artery pH (7.219 ± 0.096 vs 7.289 ± 0.085, P < 0.05).

Conclusion: Intrathecal clonidine prolongs spinal analgesia with ropivacaine and sufentanil at the expense of maternal hypotension, worse fetal well being and worse neonatal umbilical artery pH. We do not recommend routine administration of spinal clonidine 30 µg to sufentanil and ropivacaine for labour pain relief.







HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 2004 by the Canadian Anesthesiologists' Society.